doxorubicin hydrochloride and Leucocythaemia

doxorubicin hydrochloride has been researched along with Leucocythaemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Chen, F; Chen, Y; Lin, Y; Wang, J; Zhang, L; Zhang, Z1
Chen, J; Gu, X; Guan, M; Jiang, C; Li, X; Qiu, J; Song, Q; Sun, N; Zhou, Q; Zou, Y1
Chen, C; Deng, Y; He, L; Hu, M; Li, B; Li, H; Yin, H; Zhang, J1

Other Studies

3 other study(ies) available for doxorubicin hydrochloride and Leucocythaemia

ArticleYear
Design, synthesis and evaluation of the multidrug resistance-reversing activity of pyridine acid esters of podophyllotoxin in human leukemia cells.
    Bioorganic & medicinal chemistry letters, 2016, 09-15, Volume: 26, Issue:18

    Topics: Cell Line, Tumor; Drug Design; Drug Resistance, Multiple; Esters; Humans; Inhibitory Concentration 50; Leukemia; MAP Kinase Signaling System; Podophyllotoxin; Pyridines

2016
Discovery of thiosemicarbazone-containing compounds with potent anti-proliferation activity against drug-resistant K562/A02 cells.
    Bioorganic & medicinal chemistry letters, 2020, 12-15, Volume: 30, Issue:24

    Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Proliferation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; K562 Cells; Leukemia; Reactive Oxygen Species; Thiosemicarbazones

2020
Synthesis and antitumor activity of a series of novel N-aryl-5-(2,2,2-trifluoroethoxy)-1,5-dihydro-2H-pyrrol-2-ones derivatives.
    Bioorganic & medicinal chemistry letters, 2022, 10-01, Volume: 73

    Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Leukemia; Molecular Structure; Structure-Activity Relationship

2022